Education
About Us
Working with TipRanks
Follow Us
Nanexa AB (SE:NANEXA)
:NANEXA
NANEXA Stock Chart & Stats
kr3.06
kr0.05(3.79%)
At close: 4:00 PM EST
kr3.06
kr0.05(3.79%)
Day’s Range― - ―
52-Week Rangekr0.70 - kr2.91
Previous CloseN/A
Volume242.80K
Average Volume (3M)266.98K
Market Cap
kr484.76M
Enterprise Valuekr146.84M
Total Cash (Recent Filing)kr24.78M
Total Debt (Recent Filing)kr21.37M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding158,676,150
10 Day Avg. Volume346,691
30 Day Avg. Volume266,979
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)4.13
Price to Sales (P/S)12.03
P/FCF Ratio-5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanexa AB News
NANEXA FAQ
What was Nanexa AB’s price range in the past 12 months?
Nanexa AB lowest stock price was kr0.70 and its highest was kr2.90 in the past 12 months.
What is Nanexa AB’s market cap?
Nanexa AB’s market cap is kr484.76M.
When is Nanexa AB’s upcoming earnings report date?
Nanexa AB’s upcoming earnings report date is Feb 12, 2026 which is in 57 days.
How were Nanexa AB’s earnings last quarter?
Nanexa AB released its earnings results on Nov 06, 2025. The company reported -kr0.079 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.079.
Is Nanexa AB overvalued?
According to Wall Street analysts Nanexa AB’s price is currently Overvalued.
Does Nanexa AB pay dividends?
Nanexa AB does not currently pay dividends.
What is Nanexa AB’s EPS estimate?
Nanexa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanexa AB have?
Nanexa AB has 158,676,150 shares outstanding.
What happened to Nanexa AB’s price movement after its last earnings report?
Nanexa AB reported an EPS of -kr0.079 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.551%.
Which hedge fund is a major shareholder of Nanexa AB?
Currently, no hedge funds are holding shares in SE:NANEXA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanexa AB
Nanexa AB (NANEXA) is a biotechnology company specializing in drug delivery systems, particularly in the development of its proprietary platform, NEX-20, designed to enhance the efficacy and safety of therapeutic compounds. The company operates primarily in the pharmaceutical sector, focusing on the formulation and delivery of biopharmaceuticals to improve patient outcomes. Nanexa's core products include advanced drug formulations that utilize its unique technology to optimize the release profiles of active pharmaceutical ingredients.
Technical Analysis
AlzeCure Pharma AB
―
Vivesto AB
―
Klaria Pharma Holding AB
―
Enzymatica AB
―
Enorama Pharma AB
―